Venlafaxine
240 mg/day
A personal account from Pete, connecting the medicines in his existing profile with the practical experience behind JBD’s research.
Pete confirmed on 26 October 2026 that the medicines in his existing profile have not changed.
240 mg/day
15 mg/day
160 mg/day
Pete’s existing account describes using small amounts of cannabis repeatedly when neurological symptoms arise. It records 20–25 grams of flower over four to six weeks, with day-to-day use varying.
The earlier illustration used flower described as 24% THC and estimated 0.05–0.10 grams per episode. Those are the figures recorded in the account, rather than new measurements made for this page.
Different medicines can all be measured in milligrams. That common unit does not make their clinical effects or risks equivalent. This page does not use the relative mass of different substances as proof that one treatment is stronger, safer or more proportionate than another.
Pete’s account describes his experience and why continuity of care matters to him. The report’s legal and policy findings are supported separately by the original records and analysis.